NORTHSEA THERAPEUTICS
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics. The team leverages Structurally Engineered Fatty Acid (SEFA) technology to develop novel and unique therapeutic approaches targeting metabolic, inflammatory and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter- and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation and fibrosis in diverse models.
NORTHSEA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-11-17
Address:
Naarden, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.northseatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+31 (0) 35 699 30 00
Email Addresses:
[email protected]
Total Funding:
149.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins
Similar Organizations
ETHRIS
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
venBio Partners
venBio Partners investment in Series C - NorthSea Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series C - NorthSea Therapeutics
BioGeneration Ventures
BioGeneration Ventures investment in Series C - NorthSea Therapeutics
Hercules Capital
Hercules Capital investment in Series C - NorthSea Therapeutics
New Science Ventures
New Science Ventures investment in Series C - NorthSea Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - NorthSea Therapeutics
Ysios Capital
Ysios Capital investment in Series C - NorthSea Therapeutics
Novo Seeds
Novo Seeds investment in Series C - NorthSea Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - NorthSea Therapeutics
BioGeneration Ventures
BioGeneration Ventures investment in Series B - NorthSea Therapeutics
Official Site Inspections
http://www.northseatherapeutics.com Semrush global rank: 8.97 M Semrush visits lastest month: 227
- Host name: ec2-176-34-92-205.eu-west-1.compute.amazonaws.com
- IP address: 176.34.92.205
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "NorthSea Therapeutics"
NorthSea Therapeutics B.V.
NorthSea Therapeutics B.V. is a late-stage clinical technology company developing novel and innovative strategies for the treatment of metabolic, cholestatic and fibrotic diseases. We …See details»
About us | NorthSea Therapeutics B.V.
May 1, 2023 · NorthSea Therapeutics B.V. is a Dutch biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other …See details»
Contact | NorthSea Therapeutics B.V.
May 1, 2023 · NorthSea Therapeutics B.V. is a Dutch biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other …See details»
NorthSea Therapeutics - Crunchbase Company Profile & Funding
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics. View contacts for NorthSea Therapeutics to access …See details»
NorthSea Therapeutics - LinkedIn
NorthSea Therapeutics is a Clinical-stage biotech company with the aim to develop novel and innovative therapeutic strategies for NASH and other metabolic, inflammatory and fibrotic diseases....See details»
NorthSea Therapeutics Receives FDA Rare Pediatric
Oct 17, 2023 · NorthSea Therapeutics B.V. (NST) is a Dutch biotech company focused on developing structurally engineered fatty acids (‘SEFAs’) for the treatment of NASH and other metabolic disorders.See details»
NorthSea Therapeutics - Products, Competitors, Financials, …
NorthSea Therapeutics is a clinical-stage biotech company focused on the development of innovative therapeutic strategies for metabolic, inflammatory, and fibrotic diseases.See details»
NorthSea Therapeutics Completes US$80 Million Series …
Dec 17, 2021 · AMSTERDAM-- ( BUSINESS WIRE )--NorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other...See details»
NorthSea Therapeutics - Overview, News & Similar companies
Jan 9, 2020 · NorthSea Therapeutics contact info: Phone number: +31 357606505 Website: www.northseatherapeutics.com What does NorthSea Therapeutics do? NorthSea …See details»
NorthSea Therapeutics Initiates Phase 2A Trial of Orziloben (NST …
Feb 21, 2024 · The trial is a randomized, double-blind, Phase 2a, placebo-controlled study, which will be conducted at multiple sites across North America. It is designed to evaluate the safety, …See details»
NorthSea Therapeutics provides clinical update reflecting progress ...
Jan 5, 2023 · NorthSea Therapeutics B.V. (‘NST’, or the ‘Company’), a biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis …See details»
NorthSea Therapeutics Completes US$80 Million Series C …
Amsterdam, The Netherlands, 17 December 2021 – NorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for the treatment of non-alcoholic …See details»
NorthSea Therapeutics - Craft
NorthSea Therapeutics is a clinical-stage biotech company developing oral, structurally engineered fatty acid therapeutics. NorthSea Therapeutics $69.42 m in total funding,. See …See details»
NorthSea Therapeutics Completes US$80 Million Series C
Dec 17, 2021 · Amsterdam, The Netherlands, 17 December 2021 – NorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for the treatment of non …See details»
NorthSea Therapeutics to Present ICONA Phase 2b Data as an Oral …
Nov 10, 2023 · NorthSea Therapeutics B.V. (NST) is a Dutch biotech company focused on developing structurally engineered fatty acids (‘SEFAs’) for the treatment of NASH and other …See details»
NorthSea Therapeutics - PitchBook
Developer of novel and innovative therapeutic drugs designed to treat inflammatory, metabolic and liver diseases. The company's therapeutics treat dyslipidemia, insulin resistance, hepatic …See details»
NorthSea Therapeutics appoints Morris J. Birnbaum to the Board
Former Pfizer Internal Medicine CSO joins the Boardas an independent board member. Amsterdam, The Netherlands, 21 December 2022 – NorthSea Therapeutics B.V. (‘NST’), a …See details»
NorthSea Therapeutics | EU-Startups
Jun 14, 2021 · NorthSea Therapeutics is a clinical-stage biotech company developing first-in-class, oral, structurally engineered lipid therapeutics. The team leverages Structurally …See details»
NorthSea Therapeutics Announces US $40 Million Series B …
Jan 8, 2020 · NorthSea Therapeutics B.V. (NST) is a Dutch biotech company focused on developing structurally engineered fatty acids (‘SEFAs’) for the treatment of inflammatory, …See details»
Ysios Capital co-leads Northsea Therapeutic 80M$ – Ysios Capital
Dec 17, 2021 · NorthSea Therapeutics B.V. (NST) is a Dutch biotech company focused on developing structurally engineered fatty acids (‘SEFAs’) for the treatment of NASH and other …See details»